Early blood biomarkers predict organ injury and resource utilization following complex cardiac surgery

Journal of Surgical Research

Volumn 168, Issue 2, 2011, Pages 168-172

  Kim, Tad ^a   Arnaoutakis, George J ^a   Bihorac, Azra ^a   Martin, Tomas D ^a   Hess Jr , Philip J ^a   Klodell, Charles T ^a   Tribble, Curtis G ^a   Ejaz, A Ahsan ^a   Moldawer, Lyle L ^a   Beaver, Thomas Mark ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

aortic operation; biomarker; cardiac surgery; cardiopulmonary bypass; inflammatory mediator; neutrophil gelatinase associated lipocalin; thoracic aorta; valve operation

Indexed keywords

BIOLOGICAL MARKER; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RANTES;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HEALTH CARE UTILIZATION; HEART VALVE SURGERY; HOSPITALIZATION; HUMAN; IMMUNOASSAY; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG INSUFFICIENCY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; THORACIC AORTA SURGERY;

ACUTE-PHASE PROTEINS; AGED; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CYTOKINES; FEMALE; HUMANS; LENGTH OF STAY; LIPOCALINS; MALE; POSTOPERATIVE COMPLICATIONS; PROTO-ONCOGENE PROTEINS;

EID: 79955848432     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.09.023     Document Type: Article

References (19)

1. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative Renal Risk Stratification. Circulation 1997;95:878.
2. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 1998;128:194.
3. Arnaoutakis GJ, Bihorac A, Martin TD, et al. RIFLE criteria for acute kidney injury in aortic arch surgery. J Thorac Cardiovasc Surg 2007;134:1554.
4. Bellomo R, Ronco C, Kellum JA, et al., Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy, and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204.
5. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231.
6. Wan S, LeClerc JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation. Ann Thorac Surg 1997;63:269.
7. Wei M, Kuukasjärvi P, Laurikka J, et al. Cytokine response and myocardial injury in coronary artery bypass grafting. Scand J Clin Lab Invest 2001;61:161.
8. Mathur A, Baz M, Staples ED, et al. Cytokine profile after lung transplantation: Correlation with allograft injury. Ann Thorac Surg 2006;81:1844.
9. Ejaz AA, Martin TD, Johnson RJ, et al. Prophylactic Nesiritide does not prevent dialysis or all cause mortality in high-risk cardiac surgery patients. JTCVS (in press).
10. Safi HJ, Harlin SA, Miller CC, et al. Predictive factors for acute renal failure in thoracic and thoracoabdominal aortic aneurysm surgery. J Vasc Surg 1996;24:338.
11. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
12. Castellheim A, Hoel TN, Videm V, et al. Biomarker profile in off-pump and on-pump coronary artery bypass surgery grafting surgery in low-risk patients. Ann Thorac Surg 2008;85:1994.
13. Febbraio MA, Ott P, Nielsen HB, et al. Hepatosplanchnic clearance of interleukin-6 in humans during exercise. Am J Physiol Endocrinol Metab 2003;285:E397.
14. VanOtteren GM, Strieter RM, Kunkel SL, et al. Compartmentalized expression of RANTES in a murine model of endotoxemia. J Immunol 1995;154:1900.
15. Fehniger TA, Caligiuri MA. Interleukin 15: Biology and relevance to human disease. Blood 2001;97:14.
16. Gessler P, Pfenninger J, Pfammatter JP, et al. Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg 2003;126:718.
17. Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review. Kidney Int 2008;73:1008.
18. Deng J, Hu X, Yuen PS, et al. Alpha-melanocyte-stimulating hormone inhibits lung injury after renal ischemia/reperfusion. Am J Respir Crit Care Med 2004;169:749.
19. Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 1995;110:1302.